287 related articles for article (PubMed ID: 20399790)
41. Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions.
Kuzmin IV; Schwarz TM; Ilinykh PA; Jordan I; Ksiazek TG; Sachidanandam R; Basler CF; Bukreyev A
J Virol; 2017 Apr; 91(8):. PubMed ID: 28122983
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus.
Hartman AL; Bird BH; Towner JS; Antoniadou ZA; Zaki SR; Nichol ST
J Virol; 2008 Mar; 82(6):2699-704. PubMed ID: 18199658
[TBL] [Abstract][Full Text] [Related]
43. Lethality and pathogenesis of airborne infection with filoviruses in A129 α/β -/- interferon receptor-deficient mice.
Lever MS; Piercy TJ; Steward JA; Eastaugh L; Smither SJ; Taylor C; Salguero FJ; Phillpotts RJ
J Med Microbiol; 2012 Jan; 61(Pt 1):8-15. PubMed ID: 21852521
[TBL] [Abstract][Full Text] [Related]
44. Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 Peptide in Marburg Virus.
Liu B; Dong S; Li G; Wang W; Liu X; Wang Y; Yang C; Rao Z; Guo Y
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566377
[TBL] [Abstract][Full Text] [Related]
45. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.
Hartman AL; Dover JE; Towner JS; Nichol ST
J Virol; 2006 Jul; 80(13):6430-40. PubMed ID: 16775331
[TBL] [Abstract][Full Text] [Related]
46. Ebolavirus VP35 coats the backbone of double-stranded RNA for interferon antagonism.
Bale S; Julien JP; Bornholdt ZA; Krois AS; Wilson IA; Saphire EO
J Virol; 2013 Sep; 87(18):10385-8. PubMed ID: 23824825
[TBL] [Abstract][Full Text] [Related]
47. A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35-Associated Inhibition of Double-Stranded RNA-Stimulated, Retinoic Acid-Inducible Gene 1-Mediated Induction of Interferon β.
Cannas V; Daino GL; Corona A; Esposito F; Tramontano E
J Infect Dis; 2015 Oct; 212 Suppl 2():S277-81. PubMed ID: 25926684
[TBL] [Abstract][Full Text] [Related]
48. Generation and epitope mapping of a monoclonal antibody against nucleoprotein of Ebola virus.
Wang X; Liu Y; Wang H; Shi Z; Zhao F; Wei J; Shao D; Ma Z
Sheng Wu Gong Cheng Xue Bao; 2012 Nov; 28(11):1317-27. PubMed ID: 23457784
[TBL] [Abstract][Full Text] [Related]
49. A cryptic pocket in Ebola VP35 allosterically controls RNA binding.
Cruz MA; Frederick TE; Mallimadugula UL; Singh S; Vithani N; Zimmerman MI; Porter JR; Moeder KE; Amarasinghe GK; Bowman GR
Nat Commun; 2022 Apr; 13(1):2269. PubMed ID: 35477718
[TBL] [Abstract][Full Text] [Related]
50. Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery.
Chang TH; Kubota T; Matsuoka M; Jones S; Bradfute SB; Bray M; Ozato K
PLoS Pathog; 2009 Jun; 5(6):e1000493. PubMed ID: 19557165
[TBL] [Abstract][Full Text] [Related]
51. Putative endogenous filovirus VP35-like protein potentially functions as an IFN antagonist but not a polymerase cofactor.
Kondoh T; Manzoor R; Nao N; Maruyama J; Furuyama W; Miyamoto H; Shigeno A; Kuroda M; Matsuno K; Fujikura D; Kajihara M; Yoshida R; Igarashi M; Takada A
PLoS One; 2017; 12(10):e0186450. PubMed ID: 29040311
[TBL] [Abstract][Full Text] [Related]
52. The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.
Bharaj P; Atkins C; Luthra P; Giraldo MI; Dawes BE; Miorin L; Johnson JR; Krogan NJ; Basler CF; Freiberg AN; Rajsbaum R
J Virol; 2017 Sep; 91(18):. PubMed ID: 28679761
[TBL] [Abstract][Full Text] [Related]
53. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome.
Luthra P; Ramanan P; Mire CE; Weisend C; Tsuda Y; Yen B; Liu G; Leung DW; Geisbert TW; Ebihara H; Amarasinghe GK; Basler CF
Cell Host Microbe; 2013 Jul; 14(1):74-84. PubMed ID: 23870315
[TBL] [Abstract][Full Text] [Related]
54. Structure of the Ebola virus polymerase complex.
Yuan B; Peng Q; Cheng J; Wang M; Zhong J; Qi J; Gao GF; Shi Y
Nature; 2022 Oct; 610(7931):394-401. PubMed ID: 36171293
[TBL] [Abstract][Full Text] [Related]
55. Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses.
Yaddanapudi K; Palacios G; Towner JS; Chen I; Sariol CA; Nichol ST; Lipkin WI
FASEB J; 2006 Dec; 20(14):2519-30. PubMed ID: 17023517
[TBL] [Abstract][Full Text] [Related]
56. Insights into the homo-oligomerization properties of N-terminal coiled-coil domain of Ebola virus VP35 protein.
Ramaswamy VK; Di Palma F; Vargiu AV; Corona A; Piano D; Ruggerone P; Zinzula L; Tramontano E
Virus Res; 2018 Mar; 247():61-70. PubMed ID: 29427597
[TBL] [Abstract][Full Text] [Related]
57. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.
Basler CF; Mikulasova A; Martinez-Sobrido L; Paragas J; Mühlberger E; Bray M; Klenk HD; Palese P; García-Sastre A
J Virol; 2003 Jul; 77(14):7945-56. PubMed ID: 12829834
[TBL] [Abstract][Full Text] [Related]
58. Exploring the mechanism how Marburg virus VP35 recognizes and binds dsRNA by molecular dynamics simulations and free energy calculations.
Xue Q; Zheng QC; Zhang JL; Cui YL; Zhang HX
Biopolymers; 2014 Aug; 101(8):849-60. PubMed ID: 24459115
[TBL] [Abstract][Full Text] [Related]
59. Ebola virus replication is regulated by the phosphorylation of viral protein VP35.
Zhu L; Gao T; Yang W; Liu Y; Liu X; Hu Y; Jin Y; Li P; Xu K; Zou G; Zhao L; Cao R; Zhong W; Xia X; Cao C
Biochem Biophys Res Commun; 2020 Jan; 521(3):687-692. PubMed ID: 31694758
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of Marburg Virus RNA Synthesis by a Synthetic Anti-VP35 Antibody.
Amatya P; Wagner N; Chen G; Luthra P; Shi L; Borek D; Pavlenco A; Rohrs H; Basler CF; Sidhu SS; Gross ML; Leung DW
ACS Infect Dis; 2019 Aug; 5(8):1385-1396. PubMed ID: 31120240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
